BARTOLETTI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 2.197
AS - Asia 1.029
EU - Europa 606
SA - Sud America 142
AF - Africa 29
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.006
Nazione #
US - Stati Uniti d'America 2.147
SG - Singapore 480
CN - Cina 198
IT - Italia 118
BR - Brasile 112
VN - Vietnam 95
HK - Hong Kong 87
DE - Germania 84
RU - Federazione Russa 78
BD - Bangladesh 57
GB - Regno Unito 49
FR - Francia 48
UA - Ucraina 45
FI - Finlandia 41
IN - India 34
IE - Irlanda 30
SE - Svezia 29
CA - Canada 27
ES - Italia 17
BE - Belgio 16
PL - Polonia 14
TR - Turchia 13
EG - Egitto 12
MX - Messico 12
JP - Giappone 10
NL - Olanda 10
AR - Argentina 8
ID - Indonesia 8
KR - Corea 8
VE - Venezuela 8
EC - Ecuador 7
ZA - Sudafrica 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
IQ - Iraq 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
LT - Lituania 4
PK - Pakistan 4
CO - Colombia 3
RO - Romania 3
BO - Bolivia 2
CL - Cile 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
KE - Kenya 2
NG - Nigeria 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
ME - Montenegro 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 4.006
Città #
Singapore 248
Ashburn 242
Chandler 193
San Jose 153
Fairfield 132
Woodbridge 110
Beijing 94
Ann Arbor 91
Hong Kong 85
Council Bluffs 74
Houston 67
Seattle 63
New York 54
Wilmington 51
Boardman 49
Cambridge 44
Los Angeles 42
Lauterbourg 33
Ho Chi Minh City 30
Munich 30
Dublin 27
Princeton 27
Dearborn 23
Helsinki 23
Santa Clara 23
Dong Ket 19
Dallas 18
Jacksonville 18
Frankfurt am Main 16
Hanoi 16
Redmond 16
Brussels 15
Buffalo 15
São Paulo 15
London 13
Warsaw 13
Chicago 12
Montreal 12
Redondo Beach 12
Nuremberg 11
Turku 11
Poplar 10
The Dalles 10
Chennai 9
Izmir 9
Martignacco 9
Ogden 9
Orem 9
San Diego 9
Stockholm 9
Tokyo 9
Denver 8
Hefei 8
Des Moines 7
Belo Horizonte 6
Boston 6
Brooklyn 6
City of London 6
Hyderabad 6
Milan 6
Newark 6
Phoenix 6
Seoul 6
Washington 6
Augusta 5
Düsseldorf 5
Haiphong 5
Johannesburg 5
San Francisco 5
Shanghai 5
Toronto 5
Andover 4
Baku 4
Brno 4
Charlotte 4
Falls Church 4
Hải Dương 4
Leawood 4
Manchester 4
Miami 4
Philadelphia 4
Rome 4
San Mateo 4
Udine 4
Zoppola 4
Al Qahirah al Jadidah 3
Athens 3
Baghdad 3
Belluno 3
Bắc Ninh 3
Caracas 3
Genoa 3
Jinan 3
Madrid 3
Majano 3
Medina 3
Mexico City 3
Nanjing 3
New Delhi 3
Pittsburgh 3
Totale 2.551
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 222
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 203
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 195
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 193
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 181
Predictive models for identification of hospitalized patients harboring KPC-producing klebsiella pneumoniae 156
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 153
Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer 152
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study 147
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 146
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 141
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 136
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 126
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 126
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 119
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 113
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 113
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 110
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 104
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: The virtual experience of the MITO cooperative group 90
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 89
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 89
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva 88
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 87
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: A retrospective MITO group study 84
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 83
Managing COVID-19 in the oncology clinic and avoiding the distraction effect 82
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer 78
The Role of Obesity in Early and Long-Term Outcomes after Surgical Excision of Lung Oligometastases from Colorectal Cancer 77
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 76
AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization 74
Emerging molecular alterations leading to histology-specific targeted therapies in ovarian cancer beyond PARP inhibitors 70
Evaluating the role of secondary surgery and PARP inhibition in platinum-sensitive ovarian cancer relapse 58
Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)2NS) for Ovarian Cancer Therapy 57
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer 54
Late peritoneal carcinomatosis from cutaneous melanoma mimicking ovarian cancer 30
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer 22
Totale 4.124
Categoria #
all - tutte 17.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.134


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022256 20 17 6 7 9 7 16 8 1 38 95 32
2022/2023381 32 42 9 50 42 83 1 37 61 3 11 10
2023/2024187 19 16 15 9 31 44 0 10 12 9 0 22
2024/2025723 31 41 28 42 46 31 66 46 76 69 93 154
2025/20261.711 201 123 91 143 261 143 182 69 153 122 153 70
2026/202727 27 0 0 0 0 0 0 0 0 0 0 0
Totale 4.124